KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash & Current Investments (2016 - 2025)

Thermo Fisher Scientific's Cash & Current Investments history spans 17 years, with the latest figure at $10.1 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Current Investments rose 81.42% year-over-year to $10.1 billion, compared with a TTM value of $10.1 billion through Dec 2025, up 81.42%, and an annual FY2025 reading of $10.1 billion, up 81.42% over the prior year.
  • Cash & Current Investments for Q4 2025 was $10.1 billion at Thermo Fisher Scientific, up from $3.5 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $12.0 billion in Q4 2021, with the low at $1.9 billion in Q3 2022.
  • Average Cash & Current Investments over 5 years is $6.0 billion, with a median of $6.0 billion recorded in 2023.
  • Year-over-year, Cash & Current Investments tumbled 75.73% in 2022 and then surged 181.62% in 2024.
  • Tracing TMO's Cash & Current Investments over 5 years: stood at $4.5 billion in 2021, then skyrocketed by 90.4% to $8.5 billion in 2022, then dropped by 5.21% to $8.1 billion in 2023, then crashed by 31.06% to $5.6 billion in 2024, then skyrocketed by 81.42% to $10.1 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Cash & Current Investments are $10.1 billion (Q4 2025), $3.5 billion (Q3 2025), and $6.4 billion (Q2 2025).